期刊
CELLS
卷 11, 期 6, 页码 -出版社
MDPI
DOI: 10.3390/cells11061021
关键词
hepatic cells; epinephrine; norepinephrine; dopamine; sympathetic innervation
类别
资金
- Centre National de la Recherche Scientifique
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- University of Rennes
- Ligue contre le cancer [Comite 22-41-44]
In recent years, there has been an increasing number of research publications on the role of catecholamines in liver diseases. However, the mechanisms behind these effects are not well understood. This review focuses on the interaction between the liver and catecholamines, the expression of adrenergic and dopaminergic receptors in liver cells, and the involvement of catecholamines in physiological and pathophysiological processes. The importance of understanding these mechanisms for potential therapeutic use of adrenergic and dopaminergic antagonists is highlighted.
Over the last few years, the number of research publications about the role of catecholamines (epinephrine, norepinephrine, and dopamine) in the development of liver diseases such as liver fibrosis, fatty liver diseases, or liver cancers is constantly increasing. However, the mechanisms involved in these effects are not well understood. In this review, we first recapitulate the way the liver is in contact with catecholamines and consider liver implications in their metabolism. A focus on the expression of the adrenergic and dopaminergic receptors by the liver cells is also discussed. Involvement of catecholamines in physiological (glucose metabolism, lipids metabolism, and liver regeneration) and pathophysiological (impact on drug-metabolizing enzymes expression, liver dysfunction during sepsis, fibrosis development, or liver fatty diseases and liver cancers) processes are then discussed. This review highlights the importance of understanding the mechanisms through which catecholamines influence liver functions in order to draw benefit from the adrenergic and dopaminergic antagonists currently marketed. Indeed, as these molecules are well-known drugs, their use as therapies or adjuvant treatments in several liver diseases could be facilitated.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据